AHA

This channel contains news about the American Heart Association (AHA), including coverage of its annual meeting and guidelines. AHA is a leading resource for cardiology information, both consumer and professional.

Cardiologs, a leader in artificial intelligence (AI) cardiology diagnostics, announced the results of a clinical study that proved Cardiologs’ deep learning AI outperforms the Apple Watch ECG algorithm in the detection of atrial arrhythmias (AA), which are related to stroke risks. The data was accepted for a moderated digital poster presentation at the American Heart Association (AHA) Scientific Sessions 2021. #AHA ECG Monitoring AI

News | Artificial Intelligence

New Study Shows Cardiologs' Deep Learning AI Outperforms the Apple Watch ECG Algorithm in Detecting Atrial Arrhythmias

November 22, 2021 — Cardiologs, a leader in artificial intelligence (AI) cardiology diagnostics, announced the results ...

November 22, 2021

Videos | EP Lab

VIDEO: Advances in Electrophysiology Technology

Christine Albert, M.D., MPH, professor, chair of the Department of Cardiology and the Lee and Harold Kapelovitz ...

November 22, 2021

Videos | Genetic Testing

VIDEO: Use of Genetic Testing to Tailor Lipid Lowering Therapies

Susan Cheng, M.D., MPH, director of the Institute for Research on Healthy Aging in the Department of Cardiology at ...

November 22, 2021

Videos | Pharmaceuticals

VIDEO: Novel Therapeutics for Lowering Lipids

Susan Cheng, M.D., MPH, director of the Institute for Research on Healthy Aging in the Department of Cardiology at ...

November 22, 2021

EMPULSE Trial showed hospitalized adults taking empagliflozin had reduced rates of death or re-hospitalization due to acute heart failure. #AHA Heart Failure

News | Heart Failure

Adults With Acute Heart Failure Benefit When Treated With a Type 2 Diabetes Medication

November 19, 2021 — Adults treated with empagliflozin during hospitalization for acute heart failure experienced a ...

November 19, 2021

#AHA Stem Cell Therapy for Heart Failure Trial, DREAM-HF Trial. #AHA21

News | Stem Cell Therapies

Stem Cell Therapy for Heart Failure Reduced Major Cardiac Events and Death

November 19, 2021 — Stem cell therapy helped to reduce the number of heart attacks, strokes and death among people with ...

November 19, 2021

Rafael Díaz,M.D., director of Estudios Clínicos Latinoamérica in Rosario, Argentina

News | Coronavirus (COVID-19)

Prescription Omega-3 Pill Did Not Affect Outcome for Non-hospitalized Adults With COVID-19

November 19, 2021 — A high dose of a purified omega-3 fatty acid, available by prescription only, was well tolerated ...

November 19, 2021

Oral PCSK9 Inhibitor Lowering Cholesterol in First Human Trial

News | Pharmaceuticals

Oral PCSK9 Inhibitor Safe and Effective in Lowering Cholesterol in First Human Trial

November 19, 2021 — Results from two early clinical studies show the first version of an oral PCSK9-inhibitor ...

November 19, 2021

Coronary Artery Bypass Grafting (CABG). #AHA21

News | Cardiovascular Surgery

Moderna Announces Positive Data from Phase 2 Study of mRNA VEGF-A in Patients Undergoing CABG

November 18, 2021 — Moderna Inc. announced positive data from the AstraZeneca-led Phase 2 (EPICCURE) study evaluating ...

November 18, 2021

Repair of Tricuspid Valve Leak CTCR-MVS - Evaluating the Benefit of Concomitant Tricuspid Repair During Mitral Valve Surgery.

News | Structural Heart

Repair of Tricuspid Valve Leak During Mitral Valve Surgery May Benefit Some Adults

November 18, 2021 — Adults undergoing mitral valve surgery who have less than severe leakage of the tricuspid valve may ...

November 18, 2021

Cardiovascular Surgery Ticagrelor - significant increase in bleeding when people had bypass surgery after two to three days of discontinuing ticagrelor. #AHA #AHA21

News | Cardiovascular Surgery

Time From Stopping Blood Thinner To Bypass Surgery May Be Shortened for Select Patients

November 18, 2021 — People who are on the antiplatelet medication ticagrelor and need coronary artery bypass surgery may ...

November 18, 2021

About 57% of the people with high blood pressure achieved normal blood pressure levels after 18 months of the village doctor-led intervention program.Blood Pressure Hypertension. #AHA21

News | Hypertension

Village Doctor-led Intervention Effective in BP Control, Adds Health Care Access Options

November 18, 2021 — Village doctors who were community health workers in rural China were trained and successfully ...

November 18, 2021

News | Wearables

Novel Algorithm on Wearable Devices Can Detect Irregular Heartbeat, May Prompt Early Care

November 18, 2021 — A novel software algorithm compatible with a wide range of smartwatches and fitness trackers ...

November 18, 2021

Taking daily low-dose aspirin for seven years did not affect the risk of dementia or mental decline among adults with type 2 diabetes, according to the late-breaking ASCEND study presented at the American Heart Association’s Scientific Sessions 2021. Type 2 Diabetes and Aspirin Regimen. #AHA

News | Antiplatelet and Anticoagulation Therapies

Long-term, Low-dose Aspirin Did Not Affect Risk of Dementia in Adults With Type 2 Diabetes

November 17, 2021 — Taking daily low-dose aspirin for seven years did not affect the risk of dementia or mental decline ...

November 17, 2021

News | Atrial Fibrillation

Monitoring for Individual Triggers May Reduce Episodes of Atrial Fibrillation

November 17, 2021 — People with atrial fibrillation (AFib) who underwent individualized testing to discover triggers for ...

November 17, 2021